Comparison of the effect of histidine-rich glycoprotein and 6-aminohexanoic acid on plasmin production and fibrinolysis in vitro

Thrombosis Research

Volumn 99, Issue 2, 2000, Pages 179-186

  Horne, McDonald K ^a   Goad, James L ^a   Merryman, Paula K ^a   Cullinane, Ann M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

6 aminohexanoic acid; Fibrinolysis; Histidine rich glycoprotein

Indexed keywords

AMINOCAPROIC ACID; GLYCOPROTEIN; PLASMIN;

ARTICLE; CONTROLLED STUDY; FIBRIN CLOT; FIBRINOLYSIS; HUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING;

6-AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENTS; FIBRINOLYSIS; GLYCOPROTEINS; HISTIDINE; HUMANS; KINETICS; PLASMIN; PLASMINOGEN; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SEPHAROSE;

EID: 0034661197     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00231-0     Document Type: Article

References (25)

1. Lijnen H.R., Hoylaerts M., Collen D. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites of plasminogen. J Biol Chem. 255:1980;10214-10222.
2. Hoylaerts M., Lijnen H.R., Collen D. Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta. 673:1981;75-85.
3. Castaman G., Ruggeri M., Burei F., Rodeghiero F. High levels of histidine-rich glycoprotein and thrombotic diathesis, report of two unrelated families. Thromb Res. 69:1993;297-305.
4. Shigekiyo T., Ohshima T., Oka H., Tomonari A., Azuma H., Saito S. Congenital histidine-rich glycoprotein deficiency. Thromb Haemost. 70:1993;263-265.
5. Ehrenforth S., Aygoren-Pursun E., Hach-Wunderle V., Scharrer I. Prevalence of elevated histidine-rich glycoprotein in patients with thrombophilia - A study of 695 patients. Thromb Haemost. 71:1994;160-161.
6. Hennis B.C., Van Boheemen P.A., Koeleman B.P.C., Boomsma D.I., Engesser L., Van Wees A.G.M., Novakova I., Brommer E.J.P., Kluft C. A specific allele of the histidine-rich glycoprotein (HRG) locus is linked with elevated plasma levels of HRG in a Dutch family with thrombosis. Br J Haematol. 89:1995;845-852.
7. Souto J.C., Gari M., Falkon L., Fontcuberta J. A new case of hereditary histidine-rich glycoprotein deficiency with familial thrombophilia. Thromb Haemost. 75:1996;372-377.
8. Anglés-Cano E., Gris J.C., Schved J.F. Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism. J Lab Clin Med. 121:1993;646-653.
9. Goad K.E., Horne M.K., Gralnick H.R. Pentosan-induced thrombocytopenia. support for an immune complex mechanism Br J Haematol. 88:1994;803-808.
10. Koide T., Foster D., Yoshitake S., Davie E.W. Amino acid sequence of human histidine-rich glycoprotein derived from the nucleotide sequence of its cDNA. Biochemistry. 25:1986;2220-2225.
11. Deutsch D.G., Mertz E.T. Plasminogen. purification from human plasma by affinity chromatography Science. 170:1970;1095-1096.
12. Wallén P., Wiman B. Characterization of human plasminogen. I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations. Biochim Biophys Acta. 221:1970;20-30.
13. Chase T., Shaw E. Titration of trypsin, plasmin, and thrombin with p-nitrophenyl p′-guanidinobenzoate HCl. Meth Enzymol. 19:1970;20-27.
14. Ranby M. Studies on the kinetics of plasminogen activation by tissue plasminogen activator. Biochim Biophys Acta. 704:1982;461-469.
15. Chmielewska J., Wiman B. Determination of tissue plasminogen activator and its "fast" inhibitor in plasma. Clin Chem. 32:1986;482-485.
16. Kosow D.P., Furie B., Forastieri H. Activation of factor X. kinetic properties of the reaction Thromb Res. 4:1974;219-227.
17. Lijnen H.R., Rylatt D.B., Collen D. Physicochemical, immunological and functional comparison of human histidine-rich glycoprotein and autorosette inhibition factor. Biochim Biophys Acta. 742:1983;109-115.
18. Cuatrecasas P., Wilchek M., Anfinsen C.B. Selective enzyme purification by affinity chromatography. Proc Nat Acad Sci. 61:1968;636-643.
19. Kluft C., Los P. Modified crossed immunoelectrophoresis to study with whole plasma the reversible complex formation of histidine-rich glycoprotein with plasminogen. Thromb Haemost. 60:1988;411-414.
20. McNicol G.P., Fletcher A.P., Alkjaersig N., Sherry S. The absorption, distribution, and excretion of ε-aminocaproic acid following oral and intravenous administration to man. J Lab Clin Med. 59:1962;15-24.
21. Hoylaerts M., Rijken D.C., Lijnen H.R., Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. The role of fibrin. J Biol Chem. 257:1982;2912-2919.
22. Lucas M.A., Fretto L.J., McKee P.A. The binding of human plasminogen to fibrin and fibrinogen. J Biol Chem. 258:1983;4249-4256.
23. Violand B.N., Byrne R., Castellino F.J. The effect of α-,ω-amino acids on human plasminogen structure and activation. J Biol Chem. 253:1978;5395-5401.
24. m for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain α, ω-amino acids Biochemistry. 21:1982;2798-2804.
25. Borza D.-B., Morgan W.T. Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-proline-rich glycoprotein. J Biol Chem. 273:1997;5493-5499.